Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment.

Melanoma is an increasingly common malignancy, and it affects a younger population than most cancers. Risk factors for melanoma include white race, sun sensitivity, family history of melanoma, and melanocytic nevi. Sunburn and intermittent sun exposure appear to increase the risk of developing melanoma. The role of population-based screening for skin cancer remains unclear. Consistent screening results in the diagnosis of thinner melanomas, but there is no evidence that this leads to decreased mortality. The ABCDs--asymmetry, border, color, diameter--can be used as a guide to differentiate melanoma from benign lesions. Suspicious pigmented lesions should undergo full thickness biopsy. Treatment consists of surgical resection, lymph node evaluation, and systemic therapy for some patients. Prognosis depends on the stage at diagnosis. Patients with melanoma require dose follow-up because they are at risk for recurrence and diagnosis of a second primary tumor. Preventive strategies for melanoma should emphasize seeking shade when outdoors, wearing protective clothing, and avoiding exposure during the peak sunlight hours.

[1]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Karnell,et al.  The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.

[3]  A. Blum,et al.  Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment , 1999, The British journal of dermatology.

[4]  Jennifer L. Schwartz,et al.  Thin primary cutaneous melanomas , 2002, Cancer.

[5]  D. Whiteman,et al.  Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies , 2004, Cancer Causes & Control.

[6]  J. Whited,et al.  The rational clinical examination. Does this patient have a mole or a melanoma? , 1998, JAMA.

[7]  M. Helfand,et al.  Counseling to Prevent Skin Cancer: A Summary of the Evidence , 2003 .

[8]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[9]  M. Perlman,et al.  American College of Preventive Medicine practice policy statement: skin protection from ultraviolet light exposure. The American College of Preventive Medicine. , 1998, American journal of preventive medicine.

[10]  M. Mihm,et al.  Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. , 2000, Annals of surgical oncology.

[11]  Robert L. Lawrence,et al.  Extending Medicare Coverage for Preventive and Other Services , 2000 .

[12]  J. Aitken,et al.  A randomised trial of population screening for melanoma , 2002, Journal of medical screening.

[13]  M. Perlman,et al.  American College of Preventive Medicine policy statement: screening for skin cancer. , 1998, American journal of preventive medicine.

[14]  J. Kirkwood,et al.  Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  V. Deleo,et al.  Prevention of skin cancer. , 1988, The Journal of dermatologic surgery and oncology.

[16]  A. Berg Counseling to prevent skin cancer , 2004 .

[17]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[18]  J. A. Bishop,et al.  Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. , 2002, Archives of surgery.

[19]  M. Gore,et al.  Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. , 2003, Cancer treatment reviews.

[20]  Donald R. Miller,et al.  Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program. , 2002, Cancer.

[21]  C. Begg,et al.  Screening for cutaneous melanoma by skin self-examination. , 1996, Journal of the National Cancer Institute.

[22]  M. Helfand,et al.  Screening for skin cancer. , 2001, American journal of preventive medicine.

[23]  D. McCready,et al.  Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity , 2003, Journal of surgical oncology.

[24]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[25]  Hensin Tsao,et al.  A population‐based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors , 2003, Cancer.

[26]  E. Gershenwald Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy , 2007, Annals of Surgical Oncology.

[27]  Raymond L. Barnhill,et al.  Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas , 2001, Annals of Surgical Oncology.

[28]  E. Holly,et al.  Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.

[29]  A. Kopf,et al.  Early detection of malignant melanoma: The role of physician examination and self‐examination of the skin , 1985, CA: a cancer journal for clinicians.

[30]  K. Glanz,et al.  Preventing skin cancer: findings of the Task Force on Community Preventive Services On reducing Exposure to Ultraviolet Light. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[31]  G. Plewig,et al.  Risk of second primary malignancies in patients with cutaneous melanoma , 2001, The British journal of dermatology.

[32]  M. Mihm,et al.  Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm) , 2000, Annals of Surgical Oncology.

[33]  D. Rigel,et al.  Malignant melanoma: Prevention, early detection, and treatment in the 21st century , 2000, CA: a cancer journal for clinicians.

[34]  Michael Binder,et al.  Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk , 2003, Melanoma research.